<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE cstgschema SYSTEM "CStg.dtd" [
	<!ENTITY commonhistologyexclusions1 SYSTEM "commons\commonhistologyexclusions1.xml">
	<!ENTITY commontumorsizelacrimalsac SYSTEM "commons\commontumorsizelacrimalsac.xml">
	<!ENTITY commonmetslacrimalsac SYSTEM "commons\commonmetslacrimalsac.xml">
	<!ENTITY commonssf25lacrimal SYSTEM "commons\commonssf25lacrimal.xml">
	<!ENTITY commonstagelacrimaltnm6 SYSTEM "commons\commonstagelacrimaltnm6.xml">
]>
<cstgschema csschemaid= "LacrimalSac" status= "DRAFT" revised= "06/28/2011" order= "8350">
	<schemahead>
		<title>
			<maintitle>Lacrimal Sac (excluding Lymphoma)</maintitle>
			<subtitle/>
			<sitesummary>C69.5</sitesummary>
		</title>
		<note>C69.5  Lacrimal sac, lacrimal duct  </note>
		<note>Note 1:  CS Site-Specific Factor 25 is used to discriminate between lacrimal gland, staged by AJCC, and lacrimal sac, not staged by AJCC. Both sites are coded to ICD-O-3 code C69.5.</note>
		<note>Note 2:  Laterality must be coded for this site.</note>
	</schemahead>

<cstable tableid="aaz" revised="11/11/2010" pattern="1-1-0" type="desc" role="ROLE_TUMOR_SIZE" usage="ACTIVE" currency="CURRENT" externalrole="INPUT">
		<tablename>
			<tabletitle>CS Tumor Size</tabletitle>
			<tablesubtitle></tablesubtitle>
		</tablename>
	<tableheader>
		<headerrow>
			<colhead><coltitle>Code</coltitle></colhead>
			<colhead><coltitle>Description</coltitle></colhead>
		</headerrow>
	</tableheader>
		<row>
			<code>000</code>
			<descrip>No mass/tumor found</descrip>
		</row>
		<row>
			<code>001-988</code>
			<descrip><![CDATA[001 - 988 millimeters (mm) 
(Exact size to nearest mm)]]></descrip>
		</row>
		<row>
			<code>989</code>
			<descrip>989 mm or larger</descrip>
		</row>
		<row>
			<code>990</code>
			<descrip>Microscopic focus or foci only and no size of focus given</descrip>
		</row>
		<row>
			<code>991</code>
			<descrip>Described as "less than 1 centimeter (cm)"</descrip>
		</row>
		<row>
			<code>992</code>
			<descrip>Described as "less than 2 cm," or "greater than 1 cm," or "between 1 cm and 2 cm"</descrip>
		</row>
		<row>
			<code>993</code>
			<descrip>Described as "less than 3 cm," or "greater than 2 cm," or "between 2 cm and 3 cm"</descrip>
		</row>
		<row>
			<code>994</code>
			<descrip>Described as "less than 4 cm," or "greater than 3 cm," or "between 3 cm and 4 cm"</descrip>
		</row>
		<row>
			<code>995</code>
			<descrip>Described as "less than 5 cm," or "greater than 4 cm," or "between 4 cm and 5 cm"</descrip>
		</row>
		<row>
			<code>996</code>
			<descrip>Described as "greater than 5 cm"</descrip>
		</row>
		<row>
			<code>999</code>
			<descrip><![CDATA[Unknown; size not stated
Size of tumor cannot be assessed
Not documented in patient record]]></descrip>
		</row>
</cstable>

<cstable tableid="btb" revised="08/23/2010" pattern="1-1-4" type="map4" role="ROLE_EXTENSION" usage="ACTIVE" currency="CURRENT" externalrole="INPUT">
		<tablename>
			<tabletitle>CS Extension</tabletitle>
			<tablesubtitle></tablesubtitle>
		</tablename>
		<note>Note 1:  The lacrimal sac is the upper dilated end of the nasolacrimal duct, lodged in a deep groove formed by the lacrimal bone and frontal process of the maxilla. The sac connects the lacrimal canaliculi, which drain tears from the eye's surface, and the nasolacrimal duct, which conveys this fluid into the nasal cavity. The most common epithelial tumors of the lacrimal sac are squamous cell and transitional cell carcinomas.</note>
		<note>Note 2:  Periosteum is a fibrous membrane that wraps the outer surface of bones.</note>
		<note>Note 3:  AJCC excludes lacrimal sac tumors from 7th Edition staging for the lacrimal gland.  Lacrimal sac tumors were not explicitly excluded from AJCC 6th Edition staging.</note>
		<note>Note 4:  AJCC considers "in situ carcinoma of lacrimal gland" an impossible diagnosis.  Cases with extension code 000 are mapped to TX in AJCC staging.  Cases with extension code 000 are mapped to in situ in Summary Stage.</note>
	<tableheader>
		<headerrow>
			<colhead><coltitle>Code</coltitle></colhead>
			<colhead><coltitle>Description</coltitle></colhead>
			<colhead><coltitle>TNM 7 Map</coltitle></colhead>
			<colhead><coltitle>TNM 6 Map</coltitle></colhead>
			<colhead><coltitle>SS77 Map</coltitle></colhead>
			<colhead><coltitle>SS2000 Map</coltitle></colhead>
		</headerrow>
	</tableheader>
		<row>
			<code>000</code>
			<descrip>In situ, intraepithelial,  noninvasive</descrip>
			<code>NA</code>
			<code>TX</code>
			<code>IS</code>
			<code>IS</code>
		</row>
		<row>
			<code>100</code>
			<descrip>Tumor confined to lacrimal sac</descrip>
			<code>NA</code>
			<code>*</code>
			<code>L</code>
			<code>L</code>
		</row>
		<row>
			<code>300</code>
			<descrip>Localized, NOS</descrip>
			<code>NA</code>
			<code>*</code>
			<code>L</code>
			<code>L</code>
		</row>
		<row>
			<code>400</code>
			<descrip><![CDATA[OBSOLETE DATA RETAINED V0200
See code 405

Invading periosteum of fossa of lacrimal gland/duct]]></descrip>
			<code>ERROR</code>
			<code>*</code>
			<code>RE</code>
			<code>RE</code>
		</row>
		<row>
			<code>405</code>
			<descrip>Invading periosteum</descrip>
			<code>NA</code>
			<code>*</code>
			<code>RE</code>
			<code>RE</code>
		</row>
		<row>
			<code>600</code>
			<descrip><![CDATA[Extension to any of the following WITHOUT bone invasion:
    Globe (eyeball)
    Optic nerve
    Orbital soft tissues]]></descrip>
			<code>NA</code>
			<code>T4</code>
			<code>RE</code>
			<code>RE</code>
		</row>
		<row>
			<code>700</code>
			<descrip><![CDATA[Adjacent bone]]></descrip>
			<code>NA</code>
			<code>T4</code>
			<code>RE</code>
			<code>RE</code>
		</row>
		<row>
			<code>750</code>
			<descrip><![CDATA[Adjacent structures:
    Brain
    Sinus
    Pterygoid fossa
    Temporal fossa]]></descrip>
			<code>NA</code>
			<code>T4</code>
			<code>D</code>
			<code>D</code>
		</row>
		<row>
			<code>800</code>
			<descrip>Further contiguous extension</descrip>
			<code>NA</code>
			<code>T4</code>
			<code>D</code>
			<code>D</code>
		</row>
		<row>
			<code>950</code>
			<descrip>No evidence of primary tumor</descrip>
			<code>NA</code>
			<code>T0</code>
			<code>U</code>
			<code>U</code>
		</row>
		<row>
			<code>999</code>
			<descrip><![CDATA[Unknown; extension not stated
Primary tumor cannot be assessed 
Not documented in patient record]]></descrip>
			<code>NA</code>
			<code>TX</code>
			<code>U</code>
			<code>U</code>
		</row>
		<footnote>* For CS Extension codes 100-405 ONLY, the T category for AJCC 6 staging is assigned based on the value of CS Tumor Size as shown in the Extension Size AJCC 6 Table. . Tumors 2.5 cm or less are T1, and tumors between 2.6 and 5 cm are T2.</footnote>
</cstable>

<cstable tableid="cal" revised="11/03/2009" pattern="1-1-2" type="map1" role="ROLE_TUMOR_SIZE_EXT_EVAL" usage="ACTIVE" currency="CURRENT" externalrole="INPUT">
		<tablename>
			<tabletitle>CS Tumor Size/Ext Eval</tabletitle>
			<tablesubtitle></tablesubtitle>
		</tablename>
		<note>Note:  The staging basis AJCC 7 for this schema is blank because AJCC stage is not applicable in the 7th Edition.</note>
	<tableheader>
		<headerrow>
			<colhead><coltitle>Code</coltitle></colhead>
			<colhead><coltitle>Description</coltitle></colhead>
			<colhead><coltitle>Staging Basis AJCC 7</coltitle></colhead>
			<colhead><coltitle>Staging Basis AJCC 6</coltitle></colhead>
		</headerrow>
	</tableheader>
		<row>
			<code>0</code>
			<descrip><![CDATA[Does not meet criteria for AJCC pathologic staging: 
            

No surgical resection done.  Evaluation based on physical examination, imaging examination, or other non-invasive clinical evidence.  No autopsy evidence used.]]></descrip>
			<code></code>
			<code>c</code>
		</row>
		<row>
			<code>1</code>
			<descrip><![CDATA[Does not meet criteria for AJCC pathologic staging:

No surgical resection done.  Evaluation based on endoscopic examination, diagnostic biopsy, including fine needle aspiration biopsy, or other invasive techniques, including surgical observation without biopsy.  No autopsy evidence used.]]></descrip>
			<code></code>
			<code>c</code>
		</row>
		<row>
			<code>2</code>
			<descrip><![CDATA[Meets criteria for AJCC pathologic staging:

No surgical resection done, but evidence derived from autopsy (tumor was suspected or diagnosed prior to autopsy)]]></descrip>
			<code></code>
			<code>p</code>
		</row>
		<row>
			<code>3</code>
			<descrip><![CDATA[Either criteria meets AJCC pathologic staging:

Surgical resection performed WITHOUT pre-surgical systemic treatment or radiation 
OR surgical resection performed, unknown if pre-surgical systemic treatment or radiation performed
AND Evaluation based on evidence acquired before treatment, supplemented or modified by the additional evidence acquired during and from surgery, particularly from pathologic examination of the resected specimen.

No surgical resection done.  Evaluation based on positive biopsy of highest T classification.]]></descrip>
			<code></code>
			<code>p</code>
		</row>
		<row>
			<code>5</code>
			<descrip><![CDATA[Does not meet criteria for AJCC y-pathologic (yp) staging:

Surgical resection performed AFTER neoadjuvant therapy and tumor size/extension based on clinical evidence, unless the pathologic evidence at surgery (AFTER neoadjuvant) is more extensive (see code 6).]]></descrip>
			<code></code>
			<code>c</code>
		</row>
		<row>
			<code>6</code>
			<descrip><![CDATA[Meets criteria for AJCC y-pathologic (yp) staging:

Surgical resection performed AFTER neoadjuvant therapy AND tumor size/extension based on pathologic evidence,  because pathologic evidence at surgery is more extensive than clinical evidence before treatment.]]></descrip>
			<code></code>
			<code>yp</code>
		</row>
		<row>
			<code>8</code>
			<descrip><![CDATA[Meets criteria for autopsy (a) staging:

Evidence from autopsy only (tumor was unsuspected or undiagnosed prior to autopsy)]]></descrip>
			<code></code>
			<code>a</code>
		</row>
		<row>
			<code>9</code>
			<descrip><![CDATA[Unknown if surgical resection done
Not assessed; cannot be assessed
Unknown if assessed
Not documented in patient record]]></descrip>
			<code></code>
			<code>c</code>
		</row>
</cstable>

<cstable tableid="dex" revised="05/13/2011" pattern="1-1-4" type="map4" role="ROLE_LYMPH_NODES" usage="ACTIVE" currency="CURRENT" externalrole="INPUT">
		<tablename>
			<tabletitle>CS Lymph Nodes</tabletitle>
			<tablesubtitle></tablesubtitle>
		</tablename>
	<tableheader>
		<headerrow>
			<colhead><coltitle>Code</coltitle></colhead>
			<colhead><coltitle>Description</coltitle></colhead>
			<colhead><coltitle>TNM 7 Map</coltitle></colhead>
			<colhead><coltitle>TNM 6 Map</coltitle></colhead>
			<colhead><coltitle>SS77 Map</coltitle></colhead>
			<colhead><coltitle>SS2000 Map</coltitle></colhead>
		</headerrow>
	</tableheader>
		<row>
			<code>000</code>
			<descrip>No regional lymph node involvement</descrip>
			<code>NA</code>
			<code>N0</code>
			<code>NONE</code>
			<code>NONE</code>
		</row>
		<row>
			<code>100</code>
			<descrip><![CDATA[Regional lymph nodes:
    Cervical
    Submandibular (submaxillary)
    Parotid, NOS:
        Infra-auricular
        Preauricular
    Regional lymph node(s), NOS]]></descrip>
			<code>NA</code>
			<code>N1</code>
			<code>RN</code>
			<code>RN</code>
		</row>
		<row>
			<code>800</code>
			<descrip>Lymph nodes, NOS</descrip>
			<code>NA</code>
			<code>N1</code>
			<code>RN</code>
			<code>RN</code>
		</row>
		<row>
			<code>999</code>
			<descrip><![CDATA[Unknown; regional lymph nodes not stated
Regional lymph nodes cannot be assessed
Not documented in patient record]]></descrip>
			<code>NA</code>
			<code>NX</code>
			<code>U</code>
			<code>U</code>
		</row>
</cstable>

<cstable tableid="eaj" revised="11/03/2009" pattern="1-1-2" type="map1" role="ROLE_LYMPH_NODES_EVAL" usage="ACTIVE" currency="CURRENT" externalrole="INPUT">
		<tablename>
			<tabletitle>CS Lymph Nodes Eval</tabletitle>
			<tablesubtitle></tablesubtitle>
		</tablename>
		<note>Note:  The staging basis AJCC 7 for this schema is blank because AJCC stage is not applicable in the 7th Edition.</note>
	<tableheader>
		<headerrow>
			<colhead><coltitle>Code</coltitle></colhead>
			<colhead><coltitle>Description</coltitle></colhead>
			<colhead><coltitle>Staging Basis AJCC 7</coltitle></colhead>
			<colhead><coltitle>Staging Basis AJCC 6</coltitle></colhead>
		</headerrow>
	</tableheader>
		<row>
			<code>0</code>
			<descrip><![CDATA[Does not meet criteria for AJCC pathologic staging: 

No regional lymph nodes removed for examination.  Evidence based on physical examination, imaging examination, or other non-invasive clinical evidence.  No autopsy evidence used.]]></descrip>
			<code></code>
			<code>c</code>
		</row>
		<row>
			<code>1</code>
			<descrip><![CDATA[Does not meet criteria for AJCC pathologic staging based on at least one of the following criteria: 

No regional lymph nodes removed for examination.  Evidence based on endoscopic examination, or other invasive techniques including surgical observation, without biopsy.  No autopsy evidence used. 

OR 

Fine needle aspiration, incisional core needle biopsy, or excisional biopsy of regional lymph nodes or sentinel nodes as part of the diagnostic workup, WITHOUT removal of the primary site adequate for pathologic T classification (treatment).]]></descrip>
			<code></code>
			<code>c</code>
		</row>
		<row>
			<code>2</code>
			<descrip><![CDATA[Meets criteria for AJCC pathologic staging: 

No regional lymph nodes removed for examination, but evidence derived from autopsy (tumor was suspected or diagnosed prior to autopsy).]]></descrip>
			<code></code>
			<code>p</code>
		</row>
		<row>
			<code>3</code>
			<descrip><![CDATA[Meets criteria for AJCC pathologic staging based on at least one of the following criteria: 

Any microscopic assessment of regional nodes (including FNA, incisional core needle bx, excisional bx, sentinel node bx or node resection), WITH removal of the primary site adequate for pathologic T classification (treatment) or biopsy assessment of the highest T category. 

OR 

Any microscopic assessment of a regional node in the highest N category, regardless of the T category information.]]></descrip>
			<code></code>
			<code>p</code>
		</row>
		<row>
			<code>5</code>
			<descrip><![CDATA[Does not meet criteria for AJCC y-pathologic (yp) staging: 

Regional lymph nodes removed for examination AFTER neoadjuvant therapy AND lymph node evaluation based on clinical evidence, unless the pathologic evidence at surgery (AFTER neoadjuvant) is more extensive (see code 6).]]></descrip>
			<code></code>
			<code>c</code>
		</row>
		<row>
			<code>6</code>
			<descrip><![CDATA[Meets criteria for AJCC y-pathologic (yp) staging: 

Regional lymph nodes removed for examination AFTER neoadjuvant therapy AND lymph node evaluation based on pathologic evidence, because the pathologic evidence at surgery is more extensive than clinical evidence before treatment.]]></descrip>
			<code></code>
			<code>yp</code>
		</row>
		<row>
			<code>8</code>
			<descrip><![CDATA[Meets criteria for AJCC autopsy (a) staging: 

Evidence from autopsy; tumor was unsuspected or undiagnosed prior to autopsy.]]></descrip>
			<code></code>
			<code>a</code>
		</row>
		<row>
			<code>9</code>
			<descrip><![CDATA[Unknown if lymph nodes removed for examination
Not assessed; cannot be assessed
Unknown if assessed
Not documented in patient record]]></descrip>
			<code></code>
			<code>c</code>
		</row>
</cstable>

&generalreglnpos;

&generalreglnexam;

&commonmetslacrimalsac;

<cstable tableid="iae" revised="11/03/2009" pattern="1-1-2" type="map1" role="ROLE_METS_EVAL" usage="ACTIVE" currency="CURRENT" externalrole="INPUT">
		<tablename>
			<tabletitle>CS Mets Eval</tabletitle>
			<tablesubtitle></tablesubtitle>
		</tablename>
		<note>Note:  The staging basis AJCC 7 for this schema is blank because AJCC stage is not applicable in the 7th Edition.</note>
	<tableheader>
		<headerrow>
			<colhead><coltitle>Code</coltitle></colhead>
			<colhead><coltitle>Description</coltitle></colhead>
			<colhead><coltitle>Staging Basis AJCC 7</coltitle></colhead>
			<colhead><coltitle>Staging Basis AJCC 6</coltitle></colhead>
		</headerrow>
	</tableheader>
		<row>
			<code>0</code>
			<descrip><![CDATA[Does not meet criteria for AJCC pathologic staging of distant metastasis:
            

Evaluation of distant metastasis based on physical examination, imaging examination, and/or other non-invasive clinical evidence.  No pathologic examination of metastatic tissue performed or pathologic examination was negative.]]></descrip>
			<code></code>
			<code>c</code>
		</row>
		<row>
			<code>1</code>
			<descrip><![CDATA[Does not meet criteria for AJCC pathologic staging of distant metastasis:

Evaluation of distant metastasis based on endoscopic examination or other invasive technique, including surgical observation without biopsy.  No pathologic examination of metastatic tissue performed or pathologic examination was negative.]]></descrip>
			<code></code>
			<code>c</code>
		</row>
		<row>
			<code>2</code>
			<descrip><![CDATA[Meets criteria for AJCC pathologic staging of distant metastasis:

No pathologic examination of metastatic specimen done prior to death, but positive metastatic evidence derived from autopsy (tumor was suspected or diagnosed prior to autopsy).]]></descrip>
			<code></code>
			<code>p</code>
		</row>
		<row>
			<code>3</code>
			<descrip><![CDATA[Meets criteria for AJCC pathologic staging of distant metastasis:

Specimen from metastatic site microscopically positive WITHOUT pre-surgical systemic treatment or radiation 
OR specimen from metastatic site microscopically positive, unknown if pre-surgical systemic treatment or radiation performed
OR specimen from metastatic site microscopically positive prior to neoadjuvant treatment.]]></descrip>
			<code></code>
			<code>p</code>
		</row>
		<row>
			<code>5</code>
			<descrip><![CDATA[Does not meet criteria for AJCC y-pathologic (yp) staging of distant metastasis:

Specimen from metastatic site microscopically positive WITH pre-surgical systemic treatment or radiation, BUT metastasis based on clinical evidence.]]></descrip>
			<code></code>
			<code>c</code>
		</row>
		<row>
			<code>6</code>
			<descrip><![CDATA[Meets criteria for AJCC y-pathologic (yp) staging of distant metastasis:
Specimen from metastatic site microscopically positive WITH pre-surgical systemic treatment or radiation, BUT metastasis based on pathologic evidence.]]></descrip>
			<code></code>
			<code>yp</code>
		</row>
		<row>
			<code>8</code>
			<descrip><![CDATA[Meets criteria for AJCC autopsy (a) staging of distant metastasis:

Evidence from autopsy based on examination of positive metastatic tissue AND tumor was unsuspected or undiagnosed prior to autopsy.]]></descrip>
			<code></code>
			<code>a</code>
		</row>
		<row>
			<code>9</code>
			<descrip><![CDATA[Not assessed; cannot be assessed
Unknown if assessed
Not documented in patient record]]></descrip>
			<code></code>
			<code>c</code>
		</row>
</cstable>

&notappssfactor1;

&notappssfactor2;

&notappssfactor3;

&notappssfactor4;

&notappssfactor5;

&notappssfactor6;

&notappnewssf7;

&notappnewssf8;

&notappnewssf9;

&notappnewssf10;

&notappnewssf11;

&notappnewssf12;

&notappnewssf13;

&notappnewssf14;

&notappnewssf15;

&notappnewssf16;

&notappnewssf17;

&notappnewssf18;

&notappnewssf19;

&notappnewssf20;

&notappnewssf21;

&notappnewssf22;

&notappnewssf23;

&notappnewssf24;

&commonssf25lacrimal;

&notapphistologiestnm7;

&commonhistologyexclusions1;

&notappcsstagetnm7;

&commonstagelacrimaltnm6;

&commonsummarystage;

<cstable tableid="xea" revised="08/23/2010" pattern="10-0-0" type="extra" role="EXTRA_EXTENSION_SIZE_AJCC6" usage="ACTIVE" currency="CURRENT" externalrole="EXTRA">
		<tablename>
			<tabletitle>Extension Size AJCC 6 Table</tabletitle>
			<tablesubtitle></tablesubtitle>
		</tablename>
		<note>Note:  For CS Extension codes 100- 405 ONLY, the T category for AJCC 6 staging is assigned based on the value of CS Tumor Size and CS Extension as shown in this table.</note>
	<tableheader>
		<headerrow>
			<colhead><coltitle>CS Extension</coltitle></colhead>
			<colhead><coltitle>CS Tumor Size 000</coltitle>
				<range>
					<low>0</low>
				</range>
			</colhead>
			<colhead><coltitle>CS Tumor Size 001-025</coltitle>
				<range>
					<low>1</low>
					<high>25</high>
				</range>
			</colhead>
			<colhead><coltitle>CS Tumor Size 026-050</coltitle>
				<range>
					<low>26</low>
					<high>50</high>
				</range>
			</colhead>
			<colhead><coltitle>CS Tumor Size 051-989</coltitle>
				<range>
					<low>51</low>
					<high>989</high>
				</range>
			</colhead>
			<colhead><coltitle>CS Tumor Size 990-992</coltitle>
				<range>
					<low>990</low>
					<high>992</high>
				</range>
			</colhead>
			<colhead><coltitle>CS Tumor Size 993-995</coltitle>
				<range>
					<low>993</low>
					<high>995</high>
				</range>
			</colhead>
			<colhead><coltitle>CS Tumor Size 996</coltitle>
				<range>
					<low>996</low>
				</range>
			</colhead>
			<colhead><coltitle>CS Tumor Size 997-998</coltitle>
				<range>
					<low>997</low>
					<high>998</high>
				</range>
			</colhead>
			<colhead><coltitle>CS Tumor Size 999</coltitle>
				<range>
					<low>999</low>
				</range>
			</colhead>
		</headerrow>
	</tableheader>
		<row>
			<code>100</code>
			<code>ERROR</code>
			<code>T1</code>
			<code>T2</code>
			<code>T2</code>
			<code>T1</code>
			<code>T2</code>
			<code>T2</code>
			<code>ERROR</code>
			<code>TX</code>
		</row>
		<row>
			<code>300</code>
			<code>ERROR</code>
			<code>T1</code>
			<code>T2</code>
			<code>T2</code>
			<code>T1</code>
			<code>T2</code>
			<code>T2</code>
			<code>ERROR</code>
			<code>TX</code>
		</row>
		<row>
			<code>400</code>
			<code>ERROR</code>
			<code>T3a</code>
			<code>T3a</code>
			<code>T3b</code>
			<code>T3a</code>
			<code>T3a</code>
			<code>T3b</code>
			<code>ERROR</code>
			<code>T3NOS</code>
		</row>
		<row>
			<code>405</code>
			<code>ERROR</code>
			<code>T3a</code>
			<code>T3a</code>
			<code>T3b</code>
			<code>T3a</code>
			<code>T3a</code>
			<code>T3b</code>
			<code>ERROR</code>
			<code>T3NOS</code>
		</row>
</cstable>

</cstgschema>

